Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Change in Receivables (2022 - 2025)

Historic Change in Receivables for PAVmed (PAVM) over the last 4 years, with Q2 2025 value amounting to -$7000.0.

  • PAVmed's Change in Receivables fell 10460.53% to -$7000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$13000.0, marking a year-over-year change of. This contributed to the annual value of -$43000.0 for FY2024, which is 19772.73% down from last year.
  • Latest data reveals that PAVmed reported Change in Receivables of -$7000.0 as of Q2 2025, which was down 10460.53% from -$8000.0 recorded in Q1 2025.
  • Over the past 5 years, PAVmed's Change in Receivables peaked at $152000.0 during Q2 2024, and registered a low of -$111000.0 during Q1 2022.
  • In the last 4 years, PAVmed's Change in Receivables had a median value of $2000.0 in 2024 and averaged $461.54.
  • Per our database at Business Quant, PAVmed's Change in Receivables surged by 98571.43% in 2024 and then tumbled by 23333.33% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Change in Receivables stood at -$14000.0 in 2022, then surged by 285.71% to $26000.0 in 2023, then crashed by 92.31% to $2000.0 in 2024, then plummeted by 450.0% to -$7000.0 in 2025.
  • Its Change in Receivables stands at -$7000.0 for Q2 2025, versus -$8000.0 for Q1 2025 and $2000.0 for Q4 2024.